Bruna Oliveira’s Post

New publication 📝 Retrospective analysis published in Hematology provides new insights for #AcuteLymphoblasticLeukemia, see: https://loom.ly/vnLhcDM #ALLsm #leusm #MedEducation

📰Published in Seminars in Hematology Review summarizes current evidence of novel antigens & their clinical potential. Together with current CAR T-cell therapy & T-cell engagers, these approaches might lead to the next frontier   READ➡️https://lnkd.in/eMBz4c-D  #MultipleMyeloma

Mark your calendars for a live webinar hosted by Fortis Institute of Blood Disorder on Innovations in Hematology. Join us on May 17th, 2024, from 7 PM to 8 PM and gain invaluable knowledge from leading specialists Dr. Jayastu Senapati and Dr. Nikhil M Kumar. Discover new technologies and innovative practices that are shaping the future of hematology. #AtFortisWeCare #FortisHealthcare #Webinar

At #ASH24, Hammad Tashkandi, MD discussed the clinical relevance in classification methods and the prognostic implications of subgrouping within TP53-mutated myelodysplastic neoplasms as outlined by WHO and ICC. Read more: https://lnkd.in/e_SzcJXH American Society of Hematology #MoffittASH24

Especially lessons about clinical suspicion and complete blood cell abnormalities should be taught #bloodcancerawereness

IACH News of the week 20/October • 2024. Here is this week’s newsletter. A brief, up-to-date summary of the last week in hematology. https://lnkd.in/dSz-KtSy International Academy for Clinical Hematology (IACH) Mohamad Mohty CME Congresses Controversies in Multiple Myeloma (COMy)

September is #BloodCancerAwarenessMonth and an opportunity to bring much-needed focus to blood cancers such as leukemia, lymphoma, and of course, #multiplemyeloma. We know early diagnosis, effective monitoring and the right treatment are crucial for better outcomes. That’s why we’ve partnered with @Labcorp to deliver a webinar on Multiple myeloma: How primary care can support early myeloma detection. I encourage everyone – regardless of role – to take the time to hear from multiple myeloma subject matter experts @Joseph Michael, MD, Med, FRCPC, FACP, and @Saad Usmani, MD, MBA, FACP, FASCO, on early detection and referral to hematology for improved #patientoutcomes.   The Binding Site, part of Thermo Fisher Scientific #kNOwMyeloma

📘 Calling all Lab Professionals! 🌟 Exciting news! I've come across a fantastic resource that's perfect for those interested in mastering the basics of hematology in the lab. This book covers everything from blood cell morphology essentials to cutting-edge hematology technologies. It's an invaluable guide for both beginners and seasoned professionals looking to expand their knowledge. Let's elevate our expertise together! 🚀 Drop a comment if you're eager to dive into this essential read. Here's to advancing our skills in hematology diagnostics! #Hematology #LabProfessionals #ContinuousLearning #MedicalScience #BookRecommendation

New phase III study 📝 A new publication in Annals of Hematology outlines current treatments and unmet needs for patients with early/lower-risk primary #myelofibrosis and details the design of a new phase III study of ropeginterferon alfa-2b in this population, see https://loom.ly/pE6XIK0 #MPN #MPNsm

September is #BloodCancerAwareness month! Explore a primary care approach to tackling this insidious cancer and learn how early diagnosis can make a significant impact. #MultipleMyelomaAwareness #kNOmyeloma